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Introduction
============

One-third of US adults report inadequate sleep ([@B1]). Sleep problems are associated with cardiovascular disease ([@B2]), mental health problems ([@B3]), motor vehicle accidents ([@B4]), and overall poor quality of life ([@B5]). The direct and indirect costs of sleep problems are substantial ([@B6]). Despite the individual and societal burden of sleep problems, most (80%-90%) remain undiagnosed ([@B7]).

Both diabetes ([@B8]) and sleep problems ([@B5]) are highly correlated with poor quality of life. People with diabetes may also be at higher risk for sleep problems relative to the general population because of common risk factors for diabetes and sleep problems, including advanced age, obesity, and treatments for and complications of common comorbid diseases (eg, depression, cardiovascular disease). Additionally, diabetes-specific complications, such as neuropathy, could directly interfere with sleep. However, because of low rates of detected sleep disorders ([@B7]), most people with diabetes who have sleep problems are likely to go untreated. Thus, estimating the prevalence of such undiagnosed sleep problems can help determine whether these problems are a public health concern.

Although there are more than 80 recognized sleep disorders ([@B9]), studies of diabetes and sleep have focused mainly on sleep apnea ([@B10]). Additionally, most studies of diabetes and sleep problems have lacked comparisons to the general population and have depended on the diagnosis of sleep disorder. We sought to examine the association of self-reported sleep problems --- which are likely to be more prevalent than diagnosed sleep disorders --- with diabetes among community-dwelling US adults, using data from the National Health and Nutrition Examination Survey (NHANES) 2005 through 2008. We focused on the most common sleep problems: sleep apnea, insomnia, nocturia, and leg symptoms.

Methods
=======

Study design
------------

NHANES is conducted by the Centers for Disease Control and Prevention (CDC) and consists of a standardized in-home interview followed by a physical examination at a mobile examination center. NHANES uses representative samples of noninstitutionalized US civilian residents. We limited our analysis to NHANES 2005 through 2008 adult (≥20 y) participants who responded to the sleep questionnaire and completed the examination (n = 9,848). NHANES 2005 through 2006 and 2007 through 2008 reported response rates of 77.4% and 75.4% for the examined participants, respectively. All participants gave written informed consent. The National Center for Health Statistics Research Ethics Review Board approved the protocol.

Measurements
------------

**Questionnaire**

Interviewers administered a questionnaire pertaining to sleep habits and sleep-related problems ([www.cdc.gov/nchs/data/nhanes/nhanes_05_06/sp_slq_d.pdf](www.cdc.gov/nchs/data/nhanes/nhanes_05_06/sp_slq_d.pdf)), including items from 2 validated instruments: the Sleep Heart Health Study Sleep Habits Questionnaire ([@B11]) and the Functional Outcomes of Sleep Questionnaire ([@B12]). We have described individual items previously ([@B13]). Nocturia was an item on a separate kidney conditions -- urology questionnaire ([www.cdc.gov/nchs/data/nhanes/nhanes_05_06/sp_kiq_d.pdf](www.cdc.gov/nchs/data/nhanes/nhanes_05_06/sp_kiq_d.pdf)). Participants self-reported demographics (age, sex, race/ethnicity), socioeconomic status and health care access (education, income, and health insurance coverage), and health status and conditions (diagnosis of diabetes, hypertension, and cardiovascular disease \[CVD\]; smoking and alcohol use; and depressive symptoms from the Patient Health Questionnaire-9 \[PHQ-9\] \[[@B14]\]) via questionnaire. The interviewer recorded prescription medications from the bottles provided by the participant.

**Examination and laboratory measurements**

Laboratory personnel performed glycohemoglobin measurements using a high-performance liquid chromatography system and assessed fasting plasma glucose concentration by a hexokinase method. Laboratory personnel also measured serum and urine creatinine by the modified kinetic method of Jaffe and urine albumin using solid-phase fluorescence immunoassay. Examination personnel recorded anthropomorphic measurements (weight and height, used to calculate body mass index \[BMI\]) and blood pressure (≥3 auscultatory measurements).

Definitions
-----------

**Sleep problems**

We used inadequate sleep, sleep deprivation, daytime sleepiness, and sleeping pill use as markers of insomnia. We defined inadequate sleep as less than 7 total hours of sleep, according to National Sleep Foundation guidelines ([@B15]) ([Box](#B0){ref-type="boxed-text"}); we defined excess sleep as 9 or more hours per night. We defined severe sleep deprivation by sleep onset latency 5 minutes or less ([@B16]). We considered daytime sleepiness and sleeping pill use to be frequent if they were reported \"often\" or more (≥5 times/mo). We defined apnea by frequent self-reported apnea, snorting, or gasping, or diagnosed sleep apnea. We defined nocturia as reported urination of 2 or more times per night. We included frequent self-reported leg jerks or cramps, or diagnosed restless legs syndrome as leg symptoms ([Box](#B0){ref-type="boxed-text"}).

###### Box. Definition and Measurement of Sleep Problems, NHANES, 2005-2008

  **Box. Definition and Measurement of Sleep Problems, NHANES, 2005-2008**                                                                                                                                                                                                                                                                                                                       
  -------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------ ----------------------------------------------
  Inadequate sleep                                                                                   How much sleep do you usually get at night on weekdays or workdays?                                                                                                            Any number of hours with upper limit of 12                                                                   \<7 h
  Severe sleep deprivation                                                                           How long does it usually take you to fall asleep?                                                                                                                              Any number of minutes with upper limit of 60                                                                 ≤5 min
  Frequent daytime sleepiness                                                                        In the past month, how often did you feel excessively or overly sleepy during the day?                                                                                         Never, rarely (1 time/mo), sometimes (2-4 times/mo), often (5-15 times/mo), almost always (16-30 times/mo)   Often/almost always
  Frequent sleeping pill use                                                                         In the past month, how often did you take sleeping pills or other medication to help you sleep?                                                                                                                                                                                             
  Apnea                                                                                              In the past 12 months, how often did you snort, gasp, or stop breathing while you were sleeping?                                                                               Never, rarely (1-2 nights/wk), occasionally (3-4 nights/wk), frequently (≥5 nights/wk)                       Often/almost always or yes and sleep apnea
  Have you ever been told by a doctor or other health professional that you have a sleep disorder?   Yes, no                                                                                                                                                                                                                                                                                     
  What was the sleep disorder?                                                                       Sleep apnea, insomnia, restless legs, other                                                                                                                                                                                                                                                 
  Nocturia[b](#T0FN2){ref-type="table-fn"}                                                           During the past 30 days, how many times per night did you most typically get up to urinate, from the time you went to bed at night until the time you got up in the morning?   Any number with upper limit of 5                                                                             ≥2 episodes/ night
  Leg symptoms                                                                                       In the past month, how often did you have leg jerks while trying to sleep?                                                                                                     Never, rarely (1 time/mo), sometimes (2-4 times/mo), often (5-15 times/mo), almost always (16-30 times/mo)   Often/almost always or yes and restless legs
  In the past month, how often did you have leg cramps while trying to sleep?                                                                                                                                                                                                                                                                                                                    
  Have you ever been told by a doctor or other health professional that you have a sleep disorder?   Yes, no                                                                                                                                                                                                                                                                                     
  What was the sleep disorder?                                                                       Sleep apnea, insomnia, restless legs, other                                                                                                                                                                                                                                                 

Abbreviation: NHANES, National Health and Nutrition Examination Survey.

Adapted by NHANES from the Sleep Heart Study Sleep Habits Questionnaire.

From kidney conditions -- urology questionnaire of NHANES.

**Diabetes**

We defined diabetes by self-report (answer of yes to the question, \"Other than during pregnancy, have you ever been told by a doctor or other health care provider that you have diabetes or sugar diabetes?\") or glycohemoglobin of 6.5% or more ([@B17]). We did not include fasting plasma glucose of 126 mg/dL or more in the main definition because of the small sample of fasting morning participants (n = 4,770).

**Other definitions**

We defined self-reported diseases by answers of yes to the question, \"Have you ever been told by a doctor or other health professional that you have \[disease or condition\].\" We defined self-reported CVD by an answer of yes to any of coronary artery disease, angina, myocardial infarction, stroke, or congestive heart failure. We defined hypertension by self-report or by measured blood pressure of 140/90 mm Hg or higher. We defined depressive symptoms by at least 5 positive responses on the PHQ-9, along with reported functional impairment. We calculated estimated glomerular filtration rate (eGFR) according to the Modification of Diet in Renal Disease equation for isotope dilution mass spectrometry traceable creatinine ([@B18]). We defined albuminuria by a single urinary albumin:creatinine ratio of 30 mg/g or more.

Statistical analysis
--------------------

We compared selected characteristics for participants with and without diabetes using χ^2^ tests for categorical variables and *t* tests for continuous variables. We calculated prevalence of sleep problems by diabetes classification. We used multivariable logistic regression to obtain adjusted odds ratios (ORs) and 95% confidence intervals (CIs); covariates were chosen both for evidence of confounding and for parsimony. We performed sensitivity analyses with different definitions of diabetes among those not reporting sleeping pill use, with further covariates, and stratified by possible effect modifiers. All analyses were performed using Stata version 10.0 (StataCorp LP, College Station, Texas) to account for study design weights, strata, and primary sampling units.

Results
=======

Characteristics of US population by diabetes status
---------------------------------------------------

Participants with diabetes were older and more likely to be non-Hispanic black, to have no high school diploma, and to be insured than those without diabetes ([Table 1](#T1){ref-type="table"}). Relative to their counterparts, those with diabetes were less likely to be daily smokers, drank fewer alcoholic beverages per week, and were more likely to have obesity, depression, hypertension, cardiovascular disease, albuminuria, and reduced kidney function and to use diuretics ([Table 1](#T1){ref-type="table"}).

Prevalence of sleep problems
----------------------------

Overall, 93% of the adult US population reported at least 1 of the problems examined ([Table 2](#T2){ref-type="table"}). Leg symptoms (41%), inadequate sleep (37%), severe sleep deprivation (29%), and nocturia (25%) were the most commonly reported problems. While frequent sleeping pill use and apnea were less commonly reported, nearly 1 in 10 reported either. Those with diabetes were more likely than those without diabetes to report multiple sleep problems (mean no. of problems, 3.1 vs 2.5; [Figure](#F1){ref-type="fig"}).

![Number of reported sleep problems by diabetes status. The mean number of problems was 2.5 for the no-diabetes group and 3.1 for the diabetes group. Differences between the 2 groups were significant at *P* \< .001 in terms of both percentage distribution and mean number of problems (calculated by using χ^2^ and *t* tests, respectively).](PCD-9-E76s01){#F1}

Association of sleep problems with diabetes
-------------------------------------------

Diabetes was associated with increased odds of inadequate sleep, frequent daytime sleepiness, restless legs symptoms, sleep apnea, and nocturia ([Table 3](#T3){ref-type="table"}). These associations were generally robust after adjustment for confounding factors. The magnitude of the associations of sleep apnea and, to a slightly lesser extent, inadequate sleep with diabetes was attenuated by adjustment for BMI but remained significant. The associations of diabetes with daytime sleepiness and inadequate sleep were rendered nonsignificant with the final adjustment for alcohol use.

Sensitivity analyses examining the association of sleep problems with diabetes defined only by glycohemoglobin showed similar results, except that the association between glycohemoglobin and sleep apnea was fully explained by BMI (data not shown). Results with diabetes defined by self-report, glychohemoglobin, and fasting plasma glucose were nearly identical to our primary analyses. When diabetes was examined by severity category (no diabetes, diabetes with glycohemoglobin \<7.5%, diabetes with glycohemoglobin \>7.5%), apnea, leg symptoms, daytime sleepiness, and nocturia (but not inadequate sleep) all showed greater odds with increasing severity in a significant, graded fashion. Diabetes duration was significantly associated with the same problems; risk increased 20% to 30% per 10 years since diagnosis.

Furthermore, the associations of diabetes with sleep problems were also similar among the subset of the population not reporting sleeping pill use (data not shown). Adjustment for other possible confounders generally did not substantially change the results: waist circumference was associated with sleep apnea (per 1-cm increase: OR, 1.03; 95% CI, 1.02-1.05), but its addition to the model did not alter the association of diabetes with apnea (OR, 1.41; 95% CI, 1.02-1.95). Similarly, the association of diabetes with nocturia was not affected by either pulse pressure (OR, 1.48; 95% CI, 1.20-1.84) or systolic blood pressure (OR, 1.48; 95% CI, 1.19-1.83). Higher income was generally associated with lower prevalence of sleep problems (with the exception of apnea, which showed the opposite association for the highest income category); however, its addition to the models did not affect the association of diabetes with sleep problems.

Stratified analyses showed that the association of sleep apnea, leg symptoms, and nocturia with diabetes was strongest among participants younger than 60 years old compared to those 60 or older (leg symptoms: OR, 1.94 vs 1.24; *P* = .006; apnea: OR, 3.52 vs 1.59; *P* \< .001; and nocturia: OR, 3.09 vs 1.55; *P* \< .001) (data not shown). The association of leg symptoms with diabetes was stronger among women than men (OR, 1.65 vs 1.28; *P* = .04). This effect modification by age and sex was not significant for any other sleep problem, and race/ethnicity did not modify the effect of these associations.

Discussion
==========

We found that sleep problems are highly prevalent in the United States. More than 90% of NHANES respondents reported any examined sleep problem and 10% to 40% reported any given problem. Inadequate sleep, frequent daytime sleepiness, apnea, leg symptoms, and nocturia were all more common among those with diabetes than those without diabetes. These associations persisted after adjustment for conditions that could contribute to poor sleep and were generally strongest among respondents who were younger and female. Although frequent sleeping pill use and severe sleep deprivation were both common, the prevalence of these problems did not differ by diabetes status.

The association of diabetes with sleep apnea, which was independent of obesity --- a risk factor for both conditions --- has been shown previously ([@B10]), as has our observed association between diabetes and restless legs symptoms ([@B19]), which may have neuropathic origins or be related to commonly used medications such as second-generation antidepressants and antihistamines. However, less is known about other sleep problems among people with diabetes. We found that nocturia and excessive sleepiness were also independently associated with diabetes. Nocturia was the most common sleep problem reported in this population, and the association with diabetes persisted even after adjustment for diuretic use. Nocturia is often not considered among the common sleep problems, but it may have deleterious effects on both sleep and quality of life ([@B20]), which was not assessed in this study. Inadequate sleep and excess sleepiness are similarly under-recognized ([@B21]) and detrimental to physical and mental health.

Although we have shown that diabetes is independently associated with increased risk of several sleep problems, the cross-sectional study design precludes causal inference, despite the magnitude and dose-response nature of the observed associations. Additionally, while we found that duration of diabetes was positively associated with increased risk of apnea, nocturia, leg symptoms, and daytime sleepiness --- suggesting a possible temporal relationship between diabetes and subsequent sleep problems --- we cannot definitively establish the directionality of the association. Previous research examining potential causal links between diabetes and sleep problems has been inconclusive. For example, a small study showed that forced sleep deprivation in healthy young men led to decreased leptin levels and increased appetite ([@B22]); another cross-sectional analysis of participants in the Sleep Heart Health Study showed that impaired glucose tolerance was more common among people with habitual sleep restriction ([@B23]), suggesting that sleep problems may lead to diabetes via physiologic mechanisms. However, the prevalence of sleep problems among patients with type 1 diabetes was found to be similar to that seen in type 2 diabetes ([@B24]). Given the difference in etiology, these results suggest that diabetes may also lead to sleep problems.

Other limitations of note include the self-report of sleep problems, which is subject to recall and detection bias. Data for neuropathy or chronic pain, pruritis, caffeine use, neck circumference, and 24-hour blood pressure were not available in the surveys analyzed. Restless legs symptoms may not be limited to leg cramps or jerks. Sleep studies were not performed. Although we were able to show that adjustment for income did not affect the association between diabetes and sleep problems, we did not have data on poverty-related stressors. Such stressors are thought to increase the \"allostatic load\" and both interfere with sleep and increase risk for chronic diseases such as diabetes ([@B25]).

However, our study also augments previous research on diabetes and sleep problems in several ways. It is a large, nationally representative study examining a comprehensive range of sleep problems, regardless of diagnosis. We were able to compare prevalence among people with diabetes to that of similar people without diabetes, to determine whether diabetes had an independent effect on sleep problems after adjustment for other factors strongly related to both diabetes and sleep, including age, sex, obesity, cardiovascular disease, depression, kidney disease, alcohol use, and income.

In conclusion, people with diabetes are more likely to have sleep problems than their counterparts of the same age, sex, and race/ethnicity without diabetes, regardless of several behaviors and comorbid conditions that could interfere with sleep. Because sleep problems and diabetes are both associated with poor quality of life ([@B5],[@B8]), further research is warranted. Such efforts should examine the possibly dual directionality of the association of diabetes and sleep problems and explore possible causal inference and associated outcomes such as quality of life, ideally in a longitudinal cohort. Our results suggest that diabetes patients should be screened for these treatable sleep problems (sleep apnea, insomnia, restless legs, and nocturia). Recognition and treatment of sleep problems, particularly in the disproportionately affected younger and female diabetes populations, could considerably improve quality of life and, possibly, clinical outcomes among these patients.
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Post-Test Questions
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Article Title:  Prevalence of Self-Reported Sleep Problems Among People With Diabetes in the United States, 2005-2008
---------------------------------------------------------------------------------------------------------------------

**CME Questions**

1.  On the basis of the study of 2005-2008 NHANES data by Dr. Plantinga and colleagues, which of the following statements about the overall prevalence of sleep problems among persons with diabetes is **most likely**correct?About half of persons in the survey reported having any sleep problem.Among persons with diabetes, the mean number of sleep problems was about 2.The study proves that diabetes causes sleep problems.People with diabetes are more likely to have sleep problems than are persons of the same age, sex, and race/ethnicity without diabetes.

2.  On the basis of the study of 2005-2008 NHANES data by Dr. Plantinga and colleagues, which of the following statements about factors modifying the prevalence of sleep problems among persons with diabetes is **most likely** correct?Adjustment for conditions that could contribute to poor sleep abolished the observed associations between sleep problems and diabetes.The observed associations between sleep problems and diabetes were strongest among older respondents.The observed associations between sleep problems and diabetes were stronger in men than in women.Duration of diabetes was positively associated with increased risk for specific sleep problems.

3.  Your patient is a 56-year-old man with type 2 diabetes. On the basis of the study of 2005-2008 NHANES data by Dr. Plantinga and colleagues, which of the following statements about the prevalence of specific sleep problems would **most likely** be correct?Adjusted risk for restless legs symptoms is increased by about 40% compared with someone without diabetes.He is at increased risk for frequent sleeping pill use compared with someone without diabetes.He is at increased risk for severe sleep deprivation compared with someone without diabetes.After adjustment for diuretic use, risk for nocturia is not increased compared with persons without diabetes.
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###### 

Characteristics of the US Adult Population, Overall and by Diabetes Status, NHANES, 2005-2008

  Characteristic                                               Total % (95% CI)[a](#T1FN1){ref-type="table-fn"} (N = 9,848)   Diabetes Status, % (95% CI)                      
  ------------------------------------------------------------ -------------------------------------------------------------- ----------------------------- ------------------ --------
  **Demographics**                                                                                                                                                             
  **Mean age, y (95% CI)**                                     46.7 (45.8-47.5)                                               45.5 (44.7-46.4)              58.9 (57.7-60.1)   \<.001
  **Sex**                                                                                                                                                                      
  Male                                                         48.0 (47.1-48.9)                                               47.9 (47.0-49.0)              48.5 (44.8-52.2)   .77
  Female                                                       52.0 (51.1-52.9)                                               52.1 (51.1-53.0)              51.5 (47.8-55.2)   
  **Race/ethnicity[c](#T1FN2){ref-type="table-fn"}**                                                                                                                           
  Non-Hispanic white                                           71.4 (66.5-75.8)                                               72.4 (67.7-76.6)              62.6 (54.2-70.3)   \<.001
  Non-Hispanic black                                           10.7 (8.3-13.7)                                                9.9 (7.6-12.8)                17.7 (13.6-22.8)   
  Mexican American                                             8.2 (6.5-10.2)                                                 8.1 (6.5-10.1)                8.8 (6.5-11.8)     
  **Socioeconomic status**                                                                                                                                                     
  **Education**                                                                                                                                                                
  \<High school                                                18.9 (16.8-21.2)                                               17.7 (15.6-20.0)              29.1 (26.0-32.5)   \<.001
  ≥High school                                                 81.1 (78.8-83.2)                                               82.3 (80.0-84.4)              70.9 (67.6-74.0)   
  **Annual household income, \$**                                                                                                                                              
  \<20,000                                                     15.4 (13.9-17.1)                                               14.6 (13.1-16.2)              22.8 (19.5-26.4)   \<.001
  20,000-44,999                                                27.8 (25.4-30.2)                                               27.1 (24.6-29.7)              33.8 (30.2-37.5)   
  45,000-74,999                                                24.2 (22.5-26.0)                                               24.6 (22.9-26.4)              21.0 (17.7-24.9)   
  ≥75,000                                                      32.6 (29.5-35.9)                                               33.8 (30.5-37.2)              22.3 (19.1-25.9)   
  **Health insurance**                                                                                                                                                         
  Not insured                                                  19.0 (16.9-21.2)                                               19.6 (17.6-21.9)              12.8 (10.4-15.7)   \<.001
  Insured                                                      81.0 (78.8-83.1)                                               80.3 (78.1-82.4)              87.2 (84.3-89.6)   
  **Clinical status**                                                                                                                                                          
  **Smoking**                                                                                                                                                                  
  Every day                                                    19.8 (17.8-21.9)                                               20.3 (18.1-22.6)              15.8 (13.3-18.7)   .01
  Sometimes/not at all                                         80.2 (78.1-82.2)                                               79.8 (77.4-81.9)              84.2 (81.3-86.7)   
  **Mean body mass index, kg/m^2^ (95% CI)**                   28.5 (28.3-28.8)                                               28.1 (27.7-28.3)              32.9 (32.3-33.5)   \<.001
  **Depression**                                                                                                                                                               
  Symptomatic by PHQ-9                                         5.1 (4.5-5.9)                                                  4.9 (4.2-5.7)                 7.2 (5.4-9.4)      .02
  Not symptomatic by PHQ-9                                     94.9 (94.1-95.6)                                               95.1 (94.3-95.8)              92.9 (90.7-94.6)   
  **Hypertension[d](#T1FN4){ref-type="table-fn"}**                                                                                                                             
  Yes                                                          41.8 (39.8-43.8)                                               38.4 (36.4-40.5)              71.8 (68.8-74.6)   \<.001
  No                                                           58.2 (56.2-60.2)                                               61.6 (59.5-63.6)              28.2 (25.4-31.2)   
  **Cardiovascular disease[e](#T1FN5){ref-type="table-fn"}**                                                                                                                   
  Yes                                                          8.7 (7.8-9.6)                                                  6.5 (5.8-7.4)                 27.2 (24.0-30.7)   \<.001
  No                                                           91.3 (90.4-92.2)                                               93.5 (92.7-94.2)              72.8 (69.3-76.0)   
  **Albuminuria status**                                                                                                                                                       
  UACR ≥30 mg/g                                                8.0 (7.2-8.8)                                                  6.1 (5.5-6.9)                 23.6 (20.6-26.8)   \<.001
  UACR \<30 mg/g                                               92.0 (91.2-92.8)                                               93.9 (93.2-94.5)              76.4 (73.2-79.4)   
  **Reduced kidney function**                                                                                                                                                  
  eGFR \<60 mL/min/1.73 m^2^                                   8.3 (7.2-9.5)                                                  7.0 (5.9-8.3)                 19.5 (16.9-22.4)   \<.001
  eGFR ≥60 mL/min/1.73 m^2^                                    91.7 (90.5-92.8)                                               93.0 (91.7-94.1)              80.5 (77.6-83.1)   
  **Mean alcoholic intake, no. of drinks/wk (95% CI)**         3.8 (3.5-4.1)                                                  4.0 (3.7-4.4)                 2.1 (1.7-2.6)      \<.001
  **Diuretic use**                                                                                                                                                             
  Yes                                                          6.0 (5.3-6.7)                                                  5.4 (4.7-6.1)                 11.3 (9.7-13.2)    \<.001
  No                                                           94.0 (93.3-94.7)                                               94.6 (93.9-95.3)              88.7 (86.8-90.3)   

Abbreviations: NHANES, National Health and Nutrition Examination Survey; CI, confidence interval; PHQ-9, patient health questionnaire, 9-item; UACR, urinary albumin:creatinine ratio; eGFR, estimated glomerular filtration rate.

Values are percentages except where indicated by the word \"mean.\"

Calculated by using χ^2^ tests for categorical variables and analysis of variance for continuous variables.

Other race/ethnicity category (including other Hispanic, Asian, Pacific Islander, and Native American) not shown because of within-category heterogeneity, but respondents in \"other\" category are included in all analyses.

Self-reported or measured blood pressure ≥140/90 mm Hg.

Self-reported.

###### 

Prevalence of Selected Sleep Problems Among US Adults, NHANES, 2005-2008

  **Problem**                   \%
  ----------------------------- ------
  Any problem                   92.6
  Leg symptoms                  41.1
  Inadequate sleep              37.0
  Severe sleep deprivation      28.7
  Nocturia                      24.5
  Frequent daytime sleepiness   18.6
  Frequent sleeping pill use    9.1
  Apnea                         8.9

Abbreviation: NHANES, National Health and Nutrition Examination Survey.

###### 

Odds of Sleep Problems for People With Diabetes, NHANES, 2005-2008

  **Problem[a](#T3FN1){ref-type="table-fn"}^,^[b](#T3FN2){ref-type="table-fn"}**   OR (95% CI) vs No Diabetes
  -------------------------------------------------------------------------------- ----------------------------
  **Inadequate sleep**                                                             
  Unadjusted                                                                       1.33 (1.16-1.52)
  Adjusted                                                                         1.16 (0.97-1.38)
  **Severe sleep deprivation**                                                     
  Unadjusted                                                                       1.05 (0.86-1.28)
  Adjusted                                                                         1.09 (0.84-1.42)
  **Frequent daytime sleepiness**                                                  
  Unadjusted                                                                       1.38 (1.15-1.65)
  Adjusted                                                                         1.26 (0.98-1.63)
  **Frequent sleeping pill use**                                                   
  Unadjusted                                                                       1.60 (1.20-2.12)
  Adjusted                                                                         1.26 (0.95-1.68)
  **Leg symptoms**                                                                 
  Unadjusted                                                                       1.68 (1.43-1.99)
  Adjusted                                                                         1.40 (1.12-1.78)
  **Sleep apnea**                                                                  
  Unadjusted                                                                       2.49 (2.01-3.08)
  Adjusted                                                                         1.45 (1.06-1.98)
  **Nocturia**                                                                     
  Unadjusted                                                                       2.91 (2.41-3.51)
  Adjusted                                                                         1.51 (1.22-1.87)

Abbreviations: NHANES, National Health and Nutrition Examination Survey; OR, odds ratio; CI, confidence interval.

See Box in Methods for definitions.

Data were adjusted for age, sex, race/ethnicity, body mass index (continuous), cardiovascular disease, depression, albuminuria, kidney function, diuretic use, and alcohol use.
